Anthem uses AI in allergy research trial

Anthem has partnered with doc.ai, an artificial intelligence platform, to explore ways of using technology to "predict when people will experience allergies or allergy patterns," Forbes reports.

Under the agreement, Anthem is sponsoring a 12-month trial in which Cambridge, Mass.-based Harvard Medical School researchers and doc.ai will explore ways of using AI to improve patient outcomes. The effort is part of the insurer's value-based care push and increased reliance on AI to assist care delivery.

"Anthem is focused on leading our industry in the safe and responsible use of artificial intelligence and emerging technologies to create a better healthcare future for all Americans," Anthem CEO and President Gail Boudreaux told Forbes. "We are pleased to partner with doc.ai on this innovative study that can have near-term benefit for our employees and, longer-term, the potential to redefine how we treat disease and manage chronic medical conditions to achieve better personalized health outcomes."

There has been some skepticism around AI and other emerging technologies, which Anthem and doc.ai acknowledge, noting that "data trials that rely on the confluence of blockchain, precision medicine and artificial intelligence are a fairly new concept."

However, AI companies are increasingly partnering with healthcare payers to shuffle through their vast amounts of data, including medical claims and patient information.

"Any initiative in healthcare using AI needs scale to succeed," doc.ai founder and CEO Walter De Brouwer told Forbes. "We are very excited to welcome Anthem as our partner in supporting and using technology to enable individuals to collect and own their health data while empowering data scientists using deep learning to collaborate with consumers, doctors and researchers to find personalized healthcare solutions."

More articles on artificial intelligence:

Amazon backed this speech-recognition startup
IBM addresses Watson Health woes by adding regional treatment advice, STAT finds
Harvard, UPenn researchers use AI to predict mortality for cancer patients

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months